ArticleBMC infectious diseases2025
Analysis of the most common causes of blood donor deferral in Southern Mozambique.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- High transmission risk of Human Immunodeficiency Virus in blood transfusions: A critical evaluation of blood bank serological tests in Mozambique.PLOS global public health · 2026Article
- Blood donor deferral patterns in Iran: six-year national analysis (2016-2021).Blood transfusion = Trasfusione del sangueArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBlood transfusion is essential in modern medicine, but transfusion of blood may present for both the blood donor as well as the recipient risks. Strategies such as pre-interview (including clinical assessment) of donors and the subsequent testing of donated blood for infectious agents are steps taken to guarantee blood transfusion safety. The information about the reasons for deferring blood donors is not only important for improving the availability of blood, but also for actions to improve the health of the population in general. This the study aimed to assess the frequency and reasons for blood donation deferrals at blood banks in southern Mozambique.
methodsThis was a cross-sectional study conducted on blood donation candidates between December 2022 and January 2024 in the provinces of Gaza and Inhambane, situated in the southern region of Mozambique. Blood donation candidates answered a questionnaire on demographic characteristics and venous blood was collected in one 6 ml K2EDTA tube samples. The plasma was separated from the whole blood and used for serological and molecular tests for HIV, HBV and HCV. Deferral data in the routine pre-interview was subsequently collected at each blood bank.
resultsA total of 3862 donors participated in the study, of which 72.2% were replacement donors. The overall donor deferral rate in pre-interview was 5.2%, with low hemoglobin being the main reason for temporary deferral at pre-interview (41.0%), followed by syphilis or other sexually transmitted infection suspect (23.0%). The HBV (50.8%) and HIV (30.5%) infections were the main reasons for permanent deferral. Male donors were less likely to be deferred for blood donation (AOR 0.63, 95% CI 0.45-0.89) compared to female donors.
conclusionThe method used to measure hemoglobin, the higher seroprevalence of infectious agents in donated blood, and the greater deferral of women may be related to the blood donors deferral protocol in Mozambique. This results reinforce the need to improve the process of clinical assessment, selection, and retention of blood donation candidates, to have consistent volunteer donors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.